Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Barbara Burtness MD
Barbara Burtness MD Advisory Board
David Henry MD
David Henry MD Advisory Board
Sara Tolaney MD, MPH
Sara M. Tolaney MD, MPH Advisory Board
See All Experts
featured
Published in Oncology

Journal Scan / Research · May 21, 2015

Survival in Patients With Chronic-Phase CML in the Tyrosine-Kinase Inhibitor Era

The Lancet Haematology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Axel Grothey MD

The Lancet Haematology
Relative Survival in Patients With Chronic-Phase Chronic Myeloid Leukemia in the Tyrosine-Kinase Inhibitor Era: Analysis of Patient Data From Six Prospective Clinical Trials
Lancet Haematol 2015 May 01;2(5)e186-e193, K Sasaki, SS Strom, S O'Brien, E Jabbour, F Ravandi, M Konopleva, G Borthakur, N Pemmaraju, N Daver, P Jain, S Pierce, H Kantarjian, JE Cortes

Further Reading

Most Read This Week

Recently Updated